GlassScriptPhysician profile
Samuel D Bigley
NPI 1851381461
$2,821.46
in general payments reported to CMS, 2019-2025
15 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $199 · 2021: $222 · 2022: $817 · 2023: $467 · 2024: $538 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,363.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $816.82 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $535.02 | 2022-2025 | Miebo, Xiidra, Infuse |
| Oyster Point Pharma, INC. | $308.29 | 2022-2025 | Tyrvaya, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $288.39 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $205.10 | 2020-2023 | Cequa |
| Alcon Vision LLC | $140.70 | 2019-2025 | Total30, Precision7, Simbrinza |
| Coopervision INC. | $128.58 | 2022-2025 | Clariti Contact Lens, Myday Contact Lens |
| Sight Sciences, INC. | $110.25 | 2025 | Tearcare System |
| Novartis Pharmaceuticals Corporation | $84.47 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $70.83 | 2020-2021 | |
| Abb Con-Cise Optical Group LLC | $60.65 | 2019 | |
| Allergan, INC. | $33.88 | 2022 | |
| Dompe US, INC. | $15.75 | 2025 | Oxervate |
| Optos, INC. | $12.26 | 2022 | |
| Biotissue Holdings INC. | $10.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Bigley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.